<DOC>
	<DOCNO>NCT01015274</DOCNO>
	<brief_summary>The long-term objective research develop non-invasive approach early assessment patient high risk future development skeletal muscle atrophy . The investigator hypothesize rate constant terminal portion isotope decay curve follow ingestion single oral dose deuterated-3-methylhistidine ( D-3MH ) provide accurate measure increase risk rate constant measure non-invasively timed spot urine sample .</brief_summary>
	<brief_title>Non-invasive Assessment Skeletal Muscle Loss Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Cachexia</mesh_term>
	<criteria>Male 3075 year old Body Mass Index ( BMI ) &lt; 27 kg/m2 Uncontrolled hypertension Glomerular filtration rate le 60 mL/min/1.73 m2 History recurrent gastrointestinal bleeding Unable unwilling provide inform consent Ongoing anticoagulant therapy</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>